Global bovine colostrum market is evaluated at US$422.370 million for the year 2019 growing at a CAGR of 2.99% reaching the market size of US$503.901 million by the year 2025. Bovine Colostrum Market is expected to grow at a significant rate in the coming years. It is a milk-based fluid that comes from the cow's breasts for a few days after the cow gives birth. The milk is temporary and should be used within a few days. After that, true cow milk appears. The milk contains a lot of proteins, fats, carbohydrates, and minerals. It also contains a variety of antibodies and prevents viruses and bacteria in a body. Bovine milk has a lot of end uses. The antibodies' properties in bovine milk are greater than regular milk. Because of that, bovine milk is consumed by athletes to build muscles, burn fat, enhance stamina and agility, and make a considerable improvement in overall performance. It also has a lot of health benefits and is used by a lot of people. The major companies are investing a considerable sum of capital into the research and development, innovation and to enhance the quality of the milk-based products. The governments worldwide have also started various R&D programs and are collaborating with the local and major companies to enhance and improve the quality of the product. With the varying consumer preferences and the surge in the awareness to use healthier products, the Bovine Colostrum milk industry is expected to grow at a significant rate in the coming years.
Enhancing Immunity and Offering Healthier Properties
Consumers have become aware of the product properties and applications. There has also been a significant change in consumer behavior and preference for a product. The bovine colostrum market will continue to grow at a significant rate as the consumers are learning about the immunity booster properties of the milk and more imperative health benefits. It reduces the symptoms of upper way infections on those who are a fitness enthusiast. It also reduces critically infectious diarrhea in people, especially with HIV/AIDS diseases. It is also beneficial for people and children with weaker immunity. It also prevents the flu and helps those who have heart diseases. The companies related to this segmentation are investing a lot in these applications to enhance their portfolio and satisfy the consumer. There are huge opportunities for companies in the infant segmentation. Bovine Colostrum provides proteins and enhances the immunity in infants and babies. There has been widespread research and studies related to the human and bovine colostrum milk properties. Human colostrum is needed for infant growth as it contains a considerable concentration of lactose. But, sometimes there is a need to support physiological growth in the infants which cannot be completely fulfilled by the human colostrum. Therefore, bovine colostrum is needed for that. Thus, the market will continue to register significant growth as there are a lot of properties in this milk product.
The Asia Pacific holds a significant share in the market and is expected to register considerable growth. North America will also hold a significant market share due to the availability of major companies and the presence of a wider dairy industry. There are a considerable number of US Biotechnology companies that have invested millions of dollars and are collaborating with various dairy companies. Asian Companies are also investing substantial resources in colostrum milk products. Europe is also expected to register decent growth.
Some of the major companies in the market areAPS Biogroup, Genceutic Naturals, Agati Healthcare Pvt Ltd., NOW Health Group Inc., Biostrum Nutritech Pvt. Ltd., PuraLife LLC., Farbest Brands, Jarrow Formulas Inc., Vivesa Holding s.r.o., iodane Pharma A/S. There has been a significant share of local dairy companies in the market. The governments worldwide provide incentives in R&D to the companies that indulge in scientific research and development of bovine colostrum products. U.S. Food and Drug Administration has given special status to the bovine colostrum product which permits the sale of the product in the market for 7 years without competition.